Company overview
AbOliGo develops a proprietary conjugation platform for fast, reproducible, and customizable antibody-oligonucleotide conjugates (AOCs) used in spatial biology, proteomics, and single-cell workflows. The company offers 3-day delivery on µg-scale production compatible with major multiplexing platforms. Their mission focuses on empowering scientists by addressing bottlenecks in multiomic analysis.
Aboligo is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents partner serving United States & Americas. Core focus areas include antibody-oligonucleotide conjugates, aocs, spatial biology, proteomics, single-cell multiomics.
Industry categories: Life Science Reagents. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://aboligo.com
- Categories
- Life Science Reagents
- Markets served
- United States & Americas
- Keywords
- antibody-oligonucleotide conjugates, aocs, spatial biology, proteomics, single-cell multiomics
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What are AbOliGo's core capabilities in AOC production?
- AbOliGo provides a proprietary platform for rapid, reproducible, and customizable antibody-oligonucleotide conjugates (AOCs) with 3-day delivery on µg-scale for spatial biology, proteomics, and single-cell applications.
- What platforms are AbOliGo AOCs compatible with?
- AbOliGo AOCs are designed for all major multiplexing platforms in multiomic analysis, including spatial biology and proteomics workflows.
- Where is AbOliGo located?
- AbOliGo is based at Moneta Research Building, Babraham Research Campus, Cambridge, UK.
Related editorial coverage
- Research Progress and Development Strategies of Antibody-Oligonucleotide Conjugates
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
